pknayak.phe's picture
Dr. Prasanta Kumar Nayak
Assistant Professor
Department of Pharmaceutical Engineering and Technology IIT BHU
Area of Interest: 

  • BPharm (2004): Biju Patnaik University of Technology, Odisha.
  • MPharm (2006): Department of Pharmaceutics, IT (BHU), Varanasi.
  • PhD (2013): Otago School of Medical Sciences, Dunedin, New Zealand.
  • Teaching: 6 years
  • Research: 10 years
  • Industrial: 4 years
  • Primarily Prophylactic Pharmacology and Prophylactic Treatment Strategies 
  • Neuropharmacology and Hippocampal Electrophysiology – Stroke, Memory Impairment, Depression, Chronic Diseases
  • Oncology  –  Pathophysiology of Breast Tumors, Brain Tumors, and Colorectal Tumors
  • Undergraduate:
    • BL101-Biology
    • BO202-Human Physiology
    • PH231-General Pharmacology
    • UHVII-Universal Human Values-II
    • UHVI-Universal Human Values-I
  • Postgraduate:
    • PH532-Advanced Pharmacology
    • PH534-Advances in Neuropharmacology
    • PH7202-Research Methodology

Kumar M and Nayak PK (2017), Psychological sequelae of myocardial infarction. Biomedicine & Pharmacotherapy 95: 487‒496.
Shivavedi N, Kumar M, Tej GN, Nayak PK (2017), Metformin and ascorbic acid combination therapy ameliorates type 2 diabetes mellitus and comorbid depression in rats. Brain Research 1674: 1‒9. doi:
Kumar M and Nayak PK (2017), Natural phytochemicals: a promising approach in the management of myocardial infarction. Biomedicine & Pharmacotherapy 92: 1138‒1139.
Srivastava P, Kumar M, Nayak PK (2016), Role of patient derived cell lines and xenografts in cancer research. The Pharmstudent 27: 40‒48.
Sethi KK, Nayak PK, Sarkar H, Verma SM (2016), A rational approach towards the development of human carbonic anhydrase inhibitors as antiepileptic agent. Med Chem (Los Angeles) 6: 405‒410. doi:10.4172/2161-0444.1000377
Nayak PK and Kerr DS (2015), Functional preservation of hippocampal CA1 by low-dose GYKI-52466 preconditioning in a rat model of hypoxic-ischemic brain injury. Brain Research 1613: 100‒109.
Nayak PK, Kerr DS (2013), Low-dose GYKI-52466: Prophylactic preconditioning confers long-term neuroprotection and functional recovery following hypoxic‒ischaemic brain injury. Neuroscience 232: 128‒138.
Nayak PK, Zhang H and Kerr DS (2013), Determination of 1-(4′-aminophenyl)-4-methyl-7,8-methylene-dioxy-2,3-benzodiazepine by high-performance liquid chromatography–diode array detection in plasma and brain in healthy and hypoxic–ischaemic rats. Neuroscience 232: 139‒150.
Mandhane S, Nayak PK, Soni D, Jain S, Ashton J, Rajamannar T (2012), Induction of glucose intolerance by acute administration of rimonabant. Pharmacology 89(5‒6): 339‒347.
Bhattamishra SK, Nayak PK, Singh PN, Singh SK (2006), Anti-inflammatory and analgesic activities of Marsilea minuta Linn. Drug Lines 9 (1&2): 42‒45.

PhD Students:
1. Mr Naveen Shivavedi, M.Pharm.
2. Mr Gullanki Naga Venkata Charan Tej, M.Pharm.
3. Mr Kaushik Neogi, M.Pharm.​

M.Pharm./M.Tech. Students:
1. Mr Atul Kumar, B.Pharm.
2. Mr Gajendra T, B.Pharm.
3. Mr Deepak Kumar, B.Pharm.
4. Mr Satyam Sharma, B.Pharm.